Fig. 1From: Risk factors and the resistance mechanisms involved in Pseudomonas aeruginosa mutation in critically ill patientsDistribution of the population according to the existence of mutation and the duration of ventilation (> or < 24 days), initial resistance, and the prescription of ceftazidime after identification of P. aeruginosaBack to article page